How Can We Show That Artificial Intelligence May Improve Our Assessment and Management of Lower Urinary Tract Dysfunctions?-ICI-RS 2024.

Journal: Neurourology and urodynamics
PMID:

Abstract

AIMS: The integration of artificial intelligence (AI) into functional urology management must be assessed for its clinical utility, but hopefully will change, perhaps to revolutionize the way LUTD and other conditions are assessed, the aim being to offer patients more rapid and effective management which enhances patient outcomes. The aim of this proposal, discussed at the ICI-RS annual meeting, is to evaluate the available evidence on AI and the way it might change the approach to urodynamic (UDS) diagnoses, including overactive bladder syndrome (OAB), and perhaps other LUTDs such as bladder outflow obstruction.

Authors

  • Enrico Finazzi Agrò
    Department of Urology, Tor Vergata Polyclinic Hospital, University of Rome, Rome, Italy.
  • Eleonora Rosato
    Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy.
  • George Bou Kheir
    Department of Urology, Ghent University Hospital, ERN Accredited Centrum, Ghent, Belgium.
  • Kevin Rademakers
    Department of Urology, Zuyderland Medical Center, Sittard-Heerlen, the Netherlands.
  • Márcio Augusto Averbeck
    Urology Department, Moinhos de Vento Hospital, Porto Alegre, Brazil.
  • Tufan Tarcan
    Department of Urology, School of Medicine, Marmara University, Istanbul, Turkey.
  • Hashim Hashim
    Bristol Urological Institute, Southmead Hospital, Bristol, UK.
  • Andrew Gammie
    Bristol Urological Institute, Southmead Hospital, Bristol, UK.
  • Sanjay Sinha
    Department of Urology, Apollo Hospitals, Hyderabad, India.
  • Qi-Xiang Song
    Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Rayan Mohamed-Ahmed
    Department of Urogynaecology, King's College Hospital, London, UK.
  • Anasofia Da Silva
    UCL Institute for Women's Health, London, UK.
  • Riccardo Lombardo
    Department of Urology, Sapienza University of Rome, Rome, Italy. rlombardo@me.com.
  • Paul Abrams
    Bristol Urological Institute, Southmead Hospital, Bristol, UK.
  • Alan Wein
    Desai Sethi Institute of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Glenn T Werneburg
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. Electronic address: wernebg@ccf.org.